Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 485-350-6 | CAS number: 405095-33-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June - September 1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- This study has been performed in compliance with GLP in Switzerland, Procedures and Principles, March 1986, issued by the Swiss federal Department of the Interior and the Intercantonal Office for the Control of Medicaments.
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 485-350-6
- EC Name:
- -
- Cas Number:
- 405095-33-2
- Molecular formula:
- C15H20N6O3
- IUPAC Name:
- Carbonic acid - 1-phenylguanidine (1:2)
- Test material form:
- solid: bulk
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Tif: RAI f (SPF)
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.5% (w/v) carboxymethylcellulose in 0.1% (w/v) aqueous polysorbate 80
- Doses:
- 1000 mg/kg, males and females
2000 mg/kg, males and females - No. of animals per sex per dose:
- 5 animals per sex per dose (total number of animals: 20)
- Control animals:
- no
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 mg/kg bw
- Remarks on result:
- other: approx. 2000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
Any other information on results incl. tables
In-life observations
Animal No. |
Observations |
Admin. day |
Days after administration |
|||||||||
1h |
3h |
5h |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
||
1000 mg/kg, males |
||||||||||||
1-5 |
Piloerection |
+ |
+ |
+ |
+ |
+ |
+ |
|
|
|
|
|
1-5 |
Hunched post |
+ |
++ |
++ |
+ |
+ |
|
|
|
|
|
|
1-5 |
Dyspnea |
++ |
++ |
++ |
+ |
|
|
|
|
|
|
|
1-5 |
red. locom. act |
|
+ |
+ |
|
|
|
|
|
|
|
|
1000 mg/kg, females |
||||||||||||
1, 3-5 |
Piloerection |
+ |
+ |
+ |
+ |
++ |
+ |
+ |
+ |
|
|
|
2 |
Piloerection |
+ |
+ |
+ |
|
|
|
|
|
|
|
|
1, 3-5 |
Hunched post |
++ |
++ |
++ |
++ |
++ |
+ |
+ |
|
|
|
|
2 |
Hunched post |
++ |
++ |
++ |
|
|
|
|
|
|
|
|
1, 3-5 |
Dyspnea |
++ |
++ |
++ |
++ |
+ |
+ |
|
|
|
|
|
2 |
Dyspnea |
++ |
++ |
++ |
|
|
|
|
|
|
|
|
1, 3-5 |
red. locom. act |
+ |
++ |
++ |
+ |
+ |
|
|
|
|
|
|
2 |
red. locom. act |
+ |
++ |
++ |
|
|
|
|
|
|
|
|
1, 3-5 |
tremor |
|
|
+ |
+ |
|
|
|
|
|
|
|
2 |
tremor |
|
|
+ |
|
|
|
|
|
|
|
|
1-5 |
ataxia |
|
|
+ |
|
|
|
|
|
|
|
|
2000 mg/kg, males |
||||||||||||
1-4 |
Piloerection |
+ |
+ |
++ |
++ |
++ |
++ |
+ |
+ |
|
|
|
5 |
Piloerection |
+ |
+ |
++ |
|
|
|
|
|
|
|
|
1-4 |
Hunched post |
+ |
++ |
++ |
++ |
+ |
+ |
+ |
|
|
|
|
5 |
Hunched post |
+ |
++ |
++ |
|
|
|
|
|
|
|
|
1-4 |
Dyspnea |
++ |
++ |
++ |
++ |
+ |
+ |
|
|
|
|
|
5 |
Dyspnea |
++ |
++ |
++ |
|
|
|
|
|
|
|
|
1-5 |
red. locom. act |
+ |
+ |
+ |
|
|
|
|
|
|
|
|
2000 mg/kg, females |
||||||||||||
1,2,5 |
Piloerection |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
|
3 |
Piloerection |
+ |
+ |
+ |
|
|
|
|
|
|
|
|
4 |
Piloerection |
+ |
+ |
+ |
+ |
|
|
|
|
|
|
|
1,2,5 |
Hunched post |
+ |
++ |
++ |
++ |
++ |
+ |
+ |
+ |
|
|
|
3 |
Hunched post |
+ |
++ |
++ |
|
|
|
|
|
|
|
|
4 |
Hunched post |
+ |
++ |
++ |
++ |
|
|
|
|
|
|
|
1,2,5 |
Dyspnea |
++ |
++ |
++ |
++ |
+ |
+ |
+ |
|
|
|
|
3 |
Dyspnea |
++ |
++ |
++ |
|
|
|
|
|
|
|
|
4 |
Dyspnea |
++ |
++ |
++ |
++ |
|
|
|
|
|
|
|
1-5 |
red. locom. act |
+ |
+ |
+ |
|
|
|
|
|
|
|
|
3 |
Tonic spasm |
|
|
+ |
|
|
|
|
|
|
|
|
+ = slight; ++ =
moderate, +++ = severe
hunched post = hunched posture
red. locom. act. = reduced locomotor activity
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LD50 in male rats: > 2000 mg/kg body weight
LD50 in female rats: > 1000, approx. 2000 mg/kg body weight
LD50 in rats of both sexes: > 2000 mg/kg body weight - Executive summary:
In an acute oral toxicity study (performed according to the OECD guideline 401), groups of young adult albino rats (Tif: RAI f (SPF)) of both sexes were given a single oral dose by gastric intubation of CA 1139 A in 0.5% (w/v) carboxymethylcellulose (in 0.1% (w/v) aqueous polysorbate 80) at doses of 1000 and 2000 mg/kg bw and observed for 14 days.
The following LD50 was determined for CA 1139 A:
LD50 in male rats: > 2000 mg/kg body weight
LD50 in female rats: > 1000, approx. 2000 mg/kg body weight
LD50 in rats of both sexes: > 2000 mg/kg body weight
Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute tests. Additionally, reduced locomotor activity was observed in all animals. In the females dosed 1000 mg/kg tremor, ataxia and respiratory sounds were noticed. In one female dosed with 2000 mg/kg tonic spasms were observed.
One female dosed with 1000 and one male and two females dosed with 2000 mg/kg died spontaneously within two days after administration.
The animals recovered within 4 to 7 days.
At necropsy, a spotted thymus was found in one female dosed with 2000 mg/kg. No deviations from normal morphology were found in the remaining animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.